Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) is a publicly traded the market company. As of October 30, 2026, CUVL trades at $5.11 with a market cap of $255.97M and a P/E ratio of 0.00. CUVL moved +0.00% today. Year to date, CUVL is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $4.88 to $8.20. Rallies surfaces CUVL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CUVL moved +0.00% today.
| Metric | Value |
|---|---|
| Price | $5.11 |
| Market Cap | $255.97M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.04% |
| 52-Week High | $8.20 |
| 52-Week Low | $4.88 |
| Volume | 1.72K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
CUVL analyst coverage data. Average price target: $0.00.